These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37200690)

  • 1. Addressing the Challenges of Chagas Disease: An Emerging Health Concern in the United States.
    Edwards MS; Stimpert KK; Montgomery SP
    Infect Dis Clin Pract (Baltim Md); 2017 May; 25(3):118-125. PubMed ID: 37200690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chagas Disease.
    Hochberg NS; Montgomery SP
    Ann Intern Med; 2023 Feb; 176(2):ITC17-ITC32. PubMed ID: 36780647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2011-2018.
    Herwaldt BL; Dougherty CP; Allen CK; Jolly JP; Brown MN; Yu P; Yu Y
    MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(29):803-805. PubMed ID: 30048425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).
    Vallejo M; Reyes PP; Martinez Garcia M; Gonzalez Garay AG
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004102. PubMed ID: 33305846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and Management of Congenital Chagas Disease in the United States.
    Edwards MS; Stimpert KK; Bialek SR; Montgomery SP
    J Pediatric Infect Dis Soc; 2019 Nov; 8(5):461-469. PubMed ID: 31016324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chagas disease in Oklahoma.
    Agudelo Higuita NI; Bronze MS; Smith JW; Montgomery SP
    Am J Med Sci; 2022 Nov; 364(5):521-528. PubMed ID: 35623395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current drug therapy and pharmaceutical challenges for Chagas disease.
    Bermudez J; Davies C; Simonazzi A; Real JP; Palma S
    Acta Trop; 2016 Apr; 156():1-16. PubMed ID: 26747009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chagas Disease Surveillance Activities - Seven States, 2017.
    Bennett C; Straily A; Haselow D; Weinstein S; Taffner R; Yaglom H; Komatsu K; Venkat H; Brown C; Byers P; Dunn J; Moncayo A; Mayes BC; Montgomery SP
    MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(26):738-741. PubMed ID: 29975678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American trypanosomiasis.
    Carod-Artal FJ
    Handb Clin Neurol; 2013; 114():103-23. PubMed ID: 23829903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chagas Disease in the United States: a Public Health Approach.
    Bern C; Messenger LA; Whitman JD; Maguire JH
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31776135
    [No Abstract]   [Full Text] [Related]  

  • 11. New Approaches for the Treatment of Chagas Disease.
    Pandey RP; Nascimento MS; Moore CE; Raj VS; Kalil J; Cunha-Neto E
    Curr Drug Targets; 2021; 22(7):835-841. PubMed ID: 33238855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on nifurtimox for treatment of Chagas disease.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2021 Apr; 57(4):251-263. PubMed ID: 33851689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neglected parasitic infections in the United States: Chagas disease.
    Montgomery SP; Starr MC; Cantey PT; Edwards MS; Meymandi SK
    Am J Trop Med Hyg; 2014 May; 90(5):814-818. PubMed ID: 24808250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-of-the-art in host-derived biomarkers of Chagas disease prognosis and early evaluation of anti-Trypanosoma cruzi treatment response.
    Cortes-Serra N; Losada-Galvan I; Pinazo MJ; Fernandez-Becerra C; Gascon J; Alonso-Padilla J
    Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165758. PubMed ID: 32169507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chagas disease.
    Rassi A; Rassi A; Marin-Neto JA
    Lancet; 2010 Apr; 375(9723):1388-402. PubMed ID: 20399979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021.
    Abbott A; Montgomery SP; Chancey RJ
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):371-374. PubMed ID: 35271563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clinician information sessions on diagnostic testing for Chagas disease.
    Mahoney West H; Milliren CE; Manne-Goehler J; Davis J; Gallegos J; Perez JH; Köhler JR
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010524. PubMed ID: 35709253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to benznidazole for Chagas disease in the United States-Cautious optimism?
    Alpern JD; Lopez-Velez R; Stauffer WM
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005794. PubMed ID: 28910299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital transmission of Chagas disease - Virginia, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(26):477-9. PubMed ID: 22763884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Chagas Disease in the United States.
    Meymandi S; Hernandez S; Park S; Sanchez DR; Forsyth C
    Curr Treat Options Infect Dis; 2018; 10(3):373-388. PubMed ID: 30220883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.